REGISTERED NUMBER: 12389871 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 January 2025

for

MVDERMATOLOGY LTD

Page

Company Information

1

Abridged Income Statement

2

Abridged Balance Sheet

3

Notes to the Financial Statements

4

Accountants' Report

6

Director:

M Vatve

Secretary:

I Singh

Registered office:

95 The Grove

Marton-In-Cleveland

Middlesbrough

Cleveland

TS7 8AN

Registered number:

12389871 (England and Wales)

Accountants:

Mitchell Gordon LLP

43 Coniscliffe Road

Darlington

Co. Durham

DL3 7EH

Gross profit

35,669

28,845

Administrative expenses

20,314

20,967

Operating profit

4

15,355

7,878

Interest receivable and similar income

-

1

Profit before taxation

15,355

7,879

Tax on profit

2,917

1,497

Profit for the financial year

12,438

6,382

Fixed assets

Tangible assets

5

1,508

2,770

Current assets

Cash at bank

14,617

6,698

Creditors

Amounts falling due within one year

7,987

8,889

Net current assets/(liabilities)

6,630

(2,191

)

Total assets less current liabilities

8,138

579

Provisions for liabilities

287

526

Net assets

7,851

53

Capital and reserves

Called up share capital

20

20

Retained earnings

7,831

33

Shareholders' funds

7,851

53

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 January 2025 in accordance with Section 444(2A) of the Companies Act 2006.

The financial statements were approved by the director and authorised for issue on 24 September 2025 and were signed by:

M Vatve - Director

1.	STATUTORY INFORMATION

MVDermatology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared under the going concern basis of accounting.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	OPERATING PROFIT

The operating profit is stated after charging:

31/1/25

31/1/24

£

£

Depreciation - owned assets

1,262

1,342

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 February 2024

and 31 January 2025

5,879

DEPRECIATION

At 1 February 2024

3,109

Charge for year

1,262

At 31 January 2025

4,371

NET BOOK VALUE

At 31 January 2025

1,508

At 31 January 2024

2,770

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Abridged Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MVDermatology Ltd for the year ended 31 January 2025 which comprise the Abridged Income Statement, Abridged Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at accaglobal.com/rulebook.

This report is made solely to the director of MVDermatology Ltd in accordance with the terms of our engagement letter dated 27 August 2025. Our work has been undertaken solely to prepare for your approval the financial statements of MVDermatology Ltd and state those matters that we have agreed to state to the director of MVDermatology Ltd in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at

https://www.accaglobal.com/gb/en/technical-activities/technical-resources-

search/2009/october/factsheet-163-audit-exempt-companies.html.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its director for our work or for this report.

It is your duty to ensure that MVDermatology Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of MVDermatology Ltd. You consider that MVDermatology Ltd is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of MVDermatology Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Mitchell Gordon LLP

43 Coniscliffe Road

Darlington

Co. Durham

DL3 7EH

24 September 2025